Picture of MedMira logo

MIR — MedMira News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSucker Stock

Brief: MedMira Receives CE Mark For Multiplo Complete Syphilis Antibody Test

May 12 (Reuters) - MedMira Inc  MIR.V :
    * MEDMIRA RECEIVES CE MARK FOR MULTIPLO® COMPLETE SYPHILIS
(TP/NTP) ANTIBODY TEST

Source text for Eikon:  ID:nGNX4rLPk9 
Further company coverage:  MIR.V 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on MedMira

See all news